Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
A Case of Optic Neuritis with Glial Fibrillary Acidic Protein Antibody and Secondary Ophthalmoplegia.
Spatiotemporal profiling of white matter lesions and their contribution in the pathologies of Parkinson's disease animal models.
The dual legacy of BCG: a century of tuberculosis prevention and the evolving pursuit of trained immunity-based therapies.
CD4 T cells reactive to Epstein-Barr virus late lytic antigens are enriched in individuals with multiple sclerosis.
Reconstructing regenerative niches in the central nervous system: Molecular and microenvironmental determinants of axonal regeneration.
Lead (Pb) exposure results in cell type specific changes in the mouse retina and optic nerve.
The relationship between digit ratio (2D:4D) and autoimmune diseases: A systematic review and meta-analysis.
Synthesis strategies of gold nanoclusters and their application in anti-inflammatory therapy.
Correction to "Severe Hyponatremia in the Emergency Department. Incidence of Cerebral Edema and Risk of Osmotic Demyelination Syndrome".
Zebrafish (Danio rerio) as a Model for Neurodegenerative Disease Research: Mechanisms, Biomarkers, and Translational Promise.
UNEXPECTED MECHANISMS OF REPURPOSED DRUGS IN THE PATHOGENIC PATHWAYS OF NEURODEGENERATIVE DISEASES. DISCOVERING NEW NEUROPROTECTIVE THERAPIES IN CELLULAR MODELS.
The application of low-carbohydrate diet in autoimmune diseases: Mechanisms, evidence, and prospects for clinical translation.
Bruton's Tyrosine Kinase Inhibitors in Multiple Sclerosis: Mechanistic Considerations Across Relapsing and Progressive Disease.
Identification and Targeted Correction of a Pathogenic Deep Intronic Variant.
The potential roles of nicotinic acetylcholine receptors in the pathogenesis of multiple sclerosis: A comprehensive review.
Study on chimeric recombinant spider silk protein-P(LLA-CL) material for facial nerve repair in sd rats.
MOG-IgG Positivity Does Not Equal MOGAD: Diagnostic Pitfall and Misapplication of the International MOGAD Panel Proposed Criteria in Real-World Practice.
Trends and disparities in the burden of autoimmune diseases in China and globally: A comparative analysis based on the Global Burden of Disease Study 2021.
Task-Oriented Training for Rehabilitation in Multiple Sclerosis in a Non-Hospital Setting: A Protocol for a Randomized Controlled Trial.
Infection-Driven Autoimmune Amplification Versus Molecule-Specific Immune Modulation: The Dual Role of Toxocara canis in Autoimmunity.
Real-World Treatment Adherence and Persistence with C5 Inhibitor Therapy Versus Satralizumab in Patients with Neuromyelitis Optica Spectrum Disorder in Japan.
Comorbidity of uveitis and multiple sclerosis.
First-in-Human Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single and Multiple Ascending Oral Doses of BIIB091, an Oral BTK Inhibitor, in Healthy Adult Participants.
New immunotherapies for multiple sclerosis (MS): A comprehensive review.
Non-MRI biomarkers should be accepted to guide treatment escalation in MS: Commentary.
Pages
« first
‹ previous
…
979
980
981
982
983
984
985
986
987
…
next ›
last »